Abstract

The indication for the use of mydriatics in the treatment of dosed-angle glaucoma are discussed. The value of their use consists in the elimination of pupillary block and in an antiphlogistic action. This claimed that these effects prevent the formation of posterior and peripheral anterior synechiae and thus prevent the condition from becoming chronic.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.